GSK press releases

FDA approves GSK’s BLENREP (belantamab mafodotin-blmf) for the treatment of patients with relapsed or refractory multiple myeloma

BLENREP is the fifth major medicine approval for GSK in 2020

2020-08-06

Create attached notes ...